Abstract

ABSTRACTCryptococcus-macrophage interaction is crucial in the development of cryptococcocal diseases. C. neoformans and C. gattii are major pathogenic species that occupy different niches and cause different clinical manifestations. However, the differences of macrophage interaction among these species in affecting different disease outcomes and immune responses have not been clearly addressed. Here, we examined the macrophage uptake rates, intracellular loads and intracellular proliferation rates of C. neoformans and C. gattii clinical isolates from Thailand and analyzed the effect of those interactions on fungal burdens and host immune responses. C. neoformans isolates showed a higher phagocytosis rate but lower intracellular proliferation rate than C. gattii. Indeed, the high intracellular proliferation rate of C. gattii isolates did not influence the fungal burdens in lungs and brains of infected mice, whereas infection with high-uptake C. neoformans isolates resulted in significantly higher brain burdens that associated with reduced survival rate. Interestingly, alveolar macrophages of mice infected with high-uptake C. neoformans isolates showed distinct patterns of alternatively activated macrophage (M2) gene expressions with higher Arg1, Fizz1, Il13 and lower Nos2, Ifng, Il6, Tnfa, Mcp1, csf2 and Ip10 transcripts. Corresponding to this finding, infection with high-uptake C. neoformans resulted in enhanced arginase enzyme activity, elevated IL-4 and IL-13 and lowered IL-17 in the bronchoalveolar lavage. Thus, our data suggest that the macrophage interaction with C. neoformans and C. gattii may affect different disease outcomes and the high phagocytosis rates of C. neoformans influence the induction of type-2 immune responses that support fungal dissemination and disease progression.Abbreviation: Arg1: Arginase 1; BAL: Bronchoalveolar lavage; CCL17: Chemokine (C-C motif) ligand 17; CNS: Central nervous system; CSF: Cerebrospinal fluid; Csf2: Colony-stimulating factor 2; Fizz1: Found in inflammatory zone 1; HIV: Human immunodeficiency virus; ICL: Intracellular cryptococcal load; Ifng: Interferon gamma; Ip10: IFN-g-inducible protein 10; IPR: Intracellular proliferation rate; Mcp1: Monocyte chemoattractant protein 1; Nos2: Nitric oxide synthase 2; PBS: Phosphate-Buffered Saline; Th: T helper cell; Tnfa: Tumor necrosis factor alpha.

Highlights

  • Cryptococcal disease is caused by fungal infection with two major pathogenic species, C. neoformans and C. gattii

  • We evaluated whether C. neoformans and C. gattii may differ in the intracellular fungal load and intracellular proliferation rate because they have been known to be associated with the virulence of C. neoformans and C. gattii, respectively

  • We observed no difference between the intracellular load of C. neoformans and C. gattii by counting the number of intracellular cryptococci at 18 or 24 hours (Figure 1(b,c)), the intracellular load determined as colony forming unit (CFU) of C. neoformans was higher than those of C. gattii (Figure 1(g), P = 0.0066 and Figure 1(h) = 0.0011)

Read more

Summary

Introduction

Cryptococcal disease is caused by fungal infection with two major pathogenic species, C. neoformans and C. gattii. Infection by these fungi is acquired by inhaling desiccated yeasts or basidiospores that result in pulmonary or disseminated cryptococcosis. Diseases caused by C. neoformans infection are often associated with immunocompromised hosts, while C. gattii infection has been reported to cause disease in immunocompetent individuals. The differences in primary target organs and patterns of lung and brain pathology resulting from the infection of these two species have been revealed [3,4]. The divergence in the host immune responses to these species may determine disease outcomes and be responsible for the differences in disease pathogenesis of C. neoformans and C. gatii infections

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.